Evidence mapPaperPMID 34367134Full record

ArticleFrontiers in immunology2021

Fecal Bacteria Implicated in Biofilm Production Are Enriched and Associate to Gastrointestinal Symptoms in Patients With APECED - A Pilot Study.

Iivo Hetemäki, Ching Jian, Saila Laakso, Outi Mäkitie, Anne-Maria Pajari, Willem M de Vos, T Petteri Arstila, Anne Salonen

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Global Microbiome: Core and Unique Signatures Across Diverse Populations.International journal of molecular sciences · 2026
    Pooled it
  2. Article
  3. Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort.The Journal of clinical endocrinology and metabolism · 2025
    Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Iivo HetemäkiTranslational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Ching JianHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Saila LaaksoInstitute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Outi MäkitieInstitute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Anne-Maria PajariDepartment of Food and Nutrition, University of Helsinki, Helsinki, Finland.
Willem M de VosHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
T Petteri ArstilaTranslational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Anne SalonenHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
University of Helsinki · FIKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Backgrounds and Aims: APECED is a rare autoimmune disease caused by mutations in the Autoimmune Regulator gene. A significant proportion of patients also have gastrointestinal symptoms, including malabsorption, chronic diarrhea, and obstipation. The pathological background of the gastrointestinal symptoms remains incompletely understood and involves multiple factors, with autoimmunity being the most common underlying cause. Patients with APECED have increased immune responses against gut commensals. Our objective was to evaluate whether the intestinal microbiota composition, predicted functions or fungal abundance differ between Finnish patients with APECED and healthy controls, and whether these associate to the patients' clinical phenotype and gastrointestinal symptoms. Methods: DNA was isolated from fecal samples from 15 patients with APECED (median age 46.4 years) together with 15 samples from body mass index matched healthy controls. DNA samples were subjected to analysis of the gut microbiota using 16S rRNA gene amplicon sequencing, imputed metagenomics using the PICRUSt2 algorithm, and quantitative PCR for fungi. Extensive correlations of the microbiota with patient characteristics were determined. Results: Analysis of gut microbiota indicated that both alpha- and beta-diversity were altered in patients with APECED compared to healthy controls. The fraction of Conclusions: Gut microbiota of patients with APECED is altered and enriched with predominantly gram-negative bacterial taxa that may promote biofilm formation and lead to increased exposure to LPS in the patients. The most pronounced alterations in the microbiota were associated with more severe gastrointestinal symptoms.

Indexed as

Gastrointestinal MicrobiomeMutationAdultAgedAIRE ProteinAntibodies, FungalBacteriaBiofilmsCase-Control StudiesDysbiosisFecesFemaleFinlandGastrointestinal DiseasesGenetic Predisposition to DiseaseHost-Pathogen InteractionsAIRE ProteinAntibodies, FungalImmunoglobulin GLipopolysaccharidesTranscription Factorsatopobiumautoantibodiesautoimmunitydysbiosisfaecalibacteriumgut microbiotaimmune dysregulationlps

Identifiers

PMID34367134
PMCPMC8339580
OpenAlexW3184289138

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.